Compare
Labcorp vs Privia Health Group (LH vs PRVA)
The two stocks side by side, as of the latest close. Performance is rebased to 100 at the start of the window.
Over the past year Labcorp (LH) returned +46.2% and Privia Health Group (PRVA) -2.4%; so far this year the figures are +46.1% and +3.0%.
Labcorp is the larger company by market value, about 9.5 times the size of Privia Health Group.
On trailing earnings, LH trades at 30.1 times and PRVA at 93.9 times.
Revenue grew +6.0% at LH and +19.2% at PRVA over the last year.
LH yields 0.79%. PRVA pays no dividend.
Data as of the latest close. Not investment advice.
Relative performance
| LH | PRVA | |
|---|---|---|
| Price | $366.57 | $24.42 |
| 1-day | +0.90% | +2.01% |
| YTD | +46.11% | +2.99% |
| 1 year | +46.22% | -2.40% |
| 3 years | +79.74% | +19.59% |
| Market cap | $29.8B | $3.1B |
| P/E | 30.1 | 93.9 |
| P/S | 2.04 | 1.28 |
| P/B | 3.36 | 3.82 |
| Revenue growth | +6.00% | +19.20% |
| EPS growth | +19.60% | +100.00% |
| Gross margin % | 29.0 | — |
| Net margin % | 6.9 | 1.4 |
| ROE % | 11.3 | 4.3 |
| Debt / equity | 0.66 | 0.00 |
| FCF yield % | 4.3 | 3.5 |
| Dividend yield % | 0.79 | — |
| Beta | 0.38 | 0.38 |
| RSI (14) | 69.9 | 72.6 |
| Technical rating |